Erratum to: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells (Nature Communications, (2017), 8, 1, (562), 10.1038/s41467-017-00627-z)

M. Fehlings; Y. Simoni; H. L. Penny; E. Becht; C. Y. Loh; M. M. Gubin; J. P. Ward; S. C. Wong; R. D. Schreiber; E. W. Newell

doi:10.1038/s41467-018-05468-y

Erratum to: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells (Nature Communications, (2017), 8, 1, (562), 10.1038/s41467-017-00627-z)

M. Fehlings
, Y. Simoni
, H. L. Penny
, E. Becht
, C. Y. Loh
, M. M. Gubin
, J. P. Ward
, S. C. Wong
, R. D. Schreiber
, E. W. Newell

Research output: Contribution to journal › Comment/debate

2 Scopus citations

Abstract

The original version of this Article omitted a declaration from the competing interests statement, which should have included the following: ‘R.D.S. is a cofounder, stock holder, and scientific advisory board member of Jounce Therapeutics and Neon Therapeutics, and a member of the scientific advisory boards of BioLegend, Constellation, Lytix, and NGM. He also received research funding from Janssen and Agios.’. This has now been corrected in both the PDF and HTML versions of the Article.

Original language	English
Article number	3000
Journal	Nature communications
Volume	9
Issue number	1
DOIs	https://doi.org/10.1038/s41467-018-05468-y
State	Published - Dec 1 2018

Access to Document

10.1038/s41467-018-05468-y

Fingerprint

Dive into the research topics of 'Erratum to: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells (Nature Communications, (2017), 8, 1, (562), 10.1038/s41467-017-00627-z)'. Together they form a unique fingerprint.

Cite this

Fehlings, M., Simoni, Y., Penny, H. L., Becht, E., Loh, C. Y., Gubin, M. M., Ward, J. P., Wong, S. C., Schreiber, R. D., & Newell, E. W. (2018). Erratum to: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells (Nature Communications, (2017), 8, 1, (562), 10.1038/s41467-017-00627-z). Nature communications, 9(1), Article 3000. https://doi.org/10.1038/s41467-018-05468-y

@article{1a7fe2ffb92c47949dcddf229b0430fb,

title = "Erratum to: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells (Nature Communications, (2017), 8, 1, (562), 10.1038/s41467-017-00627-z)",

abstract = "The original version of this Article omitted a declaration from the competing interests statement, which should have included the following: {\textquoteleft}R.D.S. is a cofounder, stock holder, and scientific advisory board member of Jounce Therapeutics and Neon Therapeutics, and a member of the scientific advisory boards of BioLegend, Constellation, Lytix, and NGM. He also received research funding from Janssen and Agios.{\textquoteright}. This has now been corrected in both the PDF and HTML versions of the Article.",

author = "M. Fehlings and Y. Simoni and Penny, \{H. L.\} and E. Becht and Loh, \{C. Y.\} and Gubin, \{M. M.\} and Ward, \{J. P.\} and Wong, \{S. C.\} and Schreiber, \{R. D.\} and Newell, \{E. W.\}",

note = "Publisher Copyright: {\textcopyright} 2018, The Author(s).",

year = "2018",

month = dec,

day = "1",

doi = "10.1038/s41467-018-05468-y",

language = "English",

volume = "9",

journal = "Nature communications",

issn = "2041-1723",

number = "1",

}

Fehlings, M, Simoni, Y, Penny, HL, Becht, E, Loh, CY, Gubin, MM, Ward, JP, Wong, SC, Schreiber, RD & Newell, EW 2018, 'Erratum to: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells (Nature Communications, (2017), 8, 1, (562), 10.1038/s41467-017-00627-z)', Nature communications, vol. 9, no. 1, 3000. https://doi.org/10.1038/s41467-018-05468-y

Erratum to: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells (Nature Communications, (2017), 8, 1, (562), 10.1038/s41467-017-00627-z). / Fehlings, M.; Simoni, Y.; Penny, H. L. et al.
In: Nature communications, Vol. 9, No. 1, 3000, 01.12.2018.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum to

T2 - Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells (Nature Communications, (2017), 8, 1, (562), 10.1038/s41467-017-00627-z)

AU - Fehlings, M.

AU - Simoni, Y.

AU - Penny, H. L.

AU - Becht, E.

AU - Loh, C. Y.

AU - Gubin, M. M.

AU - Ward, J. P.

AU - Wong, S. C.

AU - Schreiber, R. D.

AU - Newell, E. W.

PY - 2018/12/1

Y1 - 2018/12/1

N2 - The original version of this Article omitted a declaration from the competing interests statement, which should have included the following: ‘R.D.S. is a cofounder, stock holder, and scientific advisory board member of Jounce Therapeutics and Neon Therapeutics, and a member of the scientific advisory boards of BioLegend, Constellation, Lytix, and NGM. He also received research funding from Janssen and Agios.’. This has now been corrected in both the PDF and HTML versions of the Article.

AB - The original version of this Article omitted a declaration from the competing interests statement, which should have included the following: ‘R.D.S. is a cofounder, stock holder, and scientific advisory board member of Jounce Therapeutics and Neon Therapeutics, and a member of the scientific advisory boards of BioLegend, Constellation, Lytix, and NGM. He also received research funding from Janssen and Agios.’. This has now been corrected in both the PDF and HTML versions of the Article.

UR - https://www.scopus.com/pages/publications/85050754095

U2 - 10.1038/s41467-018-05468-y

DO - 10.1038/s41467-018-05468-y

M3 - Comment/debate

C2 - 30050138

AN - SCOPUS:85050754095

SN - 2041-1723

VL - 9

JO - Nature communications

JF - Nature communications

IS - 1

M1 - 3000

ER -

Fehlings M, Simoni Y, Penny HL, Becht E, Loh CY, Gubin MM et al. Erratum to: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells (Nature Communications, (2017), 8, 1, (562), 10.1038/s41467-017-00627-z). Nature communications. 2018 Dec 1;9(1):3000. doi: 10.1038/s41467-018-05468-y

Erratum to: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells (Nature Communications, (2017), 8, 1, (562), 10.1038/s41467-017-00627-z)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this